Viking Therapeutics Inc (VKTX)
US$ 24.9899-2.61%
Price Chart
Key Statistics
Market Cap
$ 3.18B
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
3.89M
52W High
$ 81.73
52W Low
$ 18.92
Dividend Yield
0.00%
Beta
0.75
Technicals
50-Day MA
26.4959
200-Day MA
45.7401
52 Week High
81.7295
52 Week Low
18.92
About VKTX
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders.
Employees
45
Headquarters
San Diego, CA
CEO
Dr. Brian Lian Ph.D.
Latest News
Is Viking Therapeutics (VKTX) a Buy as Wall Street Analysts Look Optimistic? - Yahoo Finance
3 weeks ago • Google News
Why Viking Therapeutics Stock Popped Again Today - The Motley Fool
2 weeks ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg